TOP READ in the past 7 days

FDA Expands Use Of Plavix (Clopidogrel Bisulfate) To Unstable Angina Or Heart Attack
PARIS, FRANCE -- February 28, 2002 -- Sanofi-Synthelabo and Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) has approved the antiplatelet medication Plavix® (clopidogrel bisulfate) for a new indication: acute coronary syndrome (ACS). ACS is defined as unstable angina (chest pain) and non Q-wave myocardial in ... Full Story


 
 Most read General Medicine news in the past 7 days

Papers and articles, pertaining to General Medicine, most read by your colleagues in the past 7 days

       More news...

In the past 7 days, 113 papers and articles pertaining to General Medicine were added to the DG database. For a full list click here.

 Most read General Medicine news in the past 3 months

Papers and articles, pertaining to General Medicine, most read by your colleagues in the past 3 months


Return to top of page
Contact Us | Journals | Share this resource with a colleague | Remind Me


All contents Copyright (c) 1995-2002 Doctor's Guide Publishing Limited. All rights reserved.


 
EXPLORE DOCTOR'S GUIDE
• Most Read News
• All News
• All Webcasts / CME
• All Cases
• Congress Resource Centre
• All Medical Resources




Personalise 
• Your Name and E-Mail
• Your Preferred Search Engine
• Your Web-Based E-Mail Account
• Channel Watch
• Your Preferred Language
• Favourite Journals
• Favourite Sites

SEARCH
 

General Medicine Conditions
• Asthma
• Cholesterol/Lipid disorders
• Depression
• Diabetes
• Hypertension
• Migraine
• Osteoarthritis
• Respiratory Infections

Warning | Privacy

About P\S\L Group

Unsubscribe to e-mail edition

To receive a text version of this e-mail
in the future, click here